JPWO2020247643A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020247643A5 JPWO2020247643A5 JP2021571896A JP2021571896A JPWO2020247643A5 JP WO2020247643 A5 JPWO2020247643 A5 JP WO2020247643A5 JP 2021571896 A JP2021571896 A JP 2021571896A JP 2021571896 A JP2021571896 A JP 2021571896A JP WO2020247643 A5 JPWO2020247643 A5 JP WO2020247643A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- crystalline form
- acceptable salt
- compound
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962858837P | 2019-06-07 | 2019-06-07 | |
| US62/858,837 | 2019-06-07 | ||
| PCT/US2020/036137 WO2020247643A1 (en) | 2019-06-07 | 2020-06-04 | Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl}methanol, an shp2 inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022534788A JP2022534788A (ja) | 2022-08-03 |
| JPWO2020247643A5 true JPWO2020247643A5 (ko) | 2023-06-07 |
Family
ID=71787182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571896A Pending JP2022534788A (ja) | 2019-06-07 | 2020-06-04 | Ｓｈｐ２阻害物質である｛６－［（２－アミノ－３－クロロピリジン－４－イル）スルファニル］－３－［（３ｓ，４ｓ）－４－アミノ－３－メチル－２－オキサ－８－アザスピロ［４．５］デカン－８－イル］－５－メチルピラジン－２－イル｝メタノールの固体形態 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11220501B2 (ko) |
| EP (1) | EP3980128A1 (ko) |
| JP (1) | JP2022534788A (ko) |
| KR (1) | KR20220019017A (ko) |
| CN (2) | CN115141205A (ko) |
| AU (1) | AU2020288631A1 (ko) |
| BR (1) | BR112021022635A2 (ko) |
| CA (1) | CA3142430A1 (ko) |
| IL (1) | IL288568A (ko) |
| MA (1) | MA56113A (ko) |
| MX (1) | MX2021014855A (ko) |
| SG (1) | SG11202112461QA (ko) |
| TW (1) | TW202112785A (ko) |
| WO (1) | WO2020247643A1 (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018328273A1 (en) | 2017-09-07 | 2020-03-12 | Revolution Medicines, Inc. | SHP2 inhibitor compositions and methods for treating cancer |
| EP3980128A1 (en) | 2019-06-07 | 2022-04-13 | Revolution Medicines, Inc. | Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl}methanol, an shp2 inhibitor |
| TW202313041A (zh) | 2021-06-09 | 2023-04-01 | 瑞士商諾華公司 | 包含達拉菲尼、曲美替尼和shp2抑制劑之三重藥物組合 |
| TW202317100A (zh) | 2021-06-23 | 2023-05-01 | 瑞士商諾華公司 | 包含ｋｒａｓ ｇ１２ｃ抑制劑的藥物組合及其用於治療癌症之用途 |
| WO2023031781A1 (en) | 2021-09-01 | 2023-03-09 | Novartis Ag | Pharmaceutical combinations comprising a tead inhibitor and uses thereof for the treatment of cancers |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262564A (en) | 1992-10-30 | 1993-11-16 | Octamer, Inc. | Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents |
| CN109983001B (zh) * | 2016-07-12 | 2023-04-04 | 锐新医药公司 | 作为变构shp2抑制剂的2,5-双取代型3-甲基吡嗪及2,5,6-三取代型3-甲基吡嗪 |
| AU2018328273A1 (en) | 2017-09-07 | 2020-03-12 | Revolution Medicines, Inc. | SHP2 inhibitor compositions and methods for treating cancer |
| SG11202009793TA (en) | 2018-04-10 | 2020-10-29 | Revolution Medicines Inc | Shp2 inhibitor compositions, methods for treating cancer and methods for identifying a subject with shp2 mutations |
| EP3980128A1 (en) | 2019-06-07 | 2022-04-13 | Revolution Medicines, Inc. | Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl}methanol, an shp2 inhibitor |
-
2020
- 2020-06-04 EP EP20746488.4A patent/EP3980128A1/en active Pending
- 2020-06-04 KR KR1020227000184A patent/KR20220019017A/ko unknown
- 2020-06-04 BR BR112021022635A patent/BR112021022635A2/pt unknown
- 2020-06-04 CN CN202210564150.XA patent/CN115141205A/zh active Pending
- 2020-06-04 CA CA3142430A patent/CA3142430A1/en active Pending
- 2020-06-04 JP JP2021571896A patent/JP2022534788A/ja active Pending
- 2020-06-04 WO PCT/US2020/036137 patent/WO2020247643A1/en active Application Filing
- 2020-06-04 AU AU2020288631A patent/AU2020288631A1/en not_active Abandoned
- 2020-06-04 MX MX2021014855A patent/MX2021014855A/es unknown
- 2020-06-04 TW TW109118750A patent/TW202112785A/zh unknown
- 2020-06-04 CN CN202080054905.0A patent/CN114190090A/zh active Pending
- 2020-06-04 MA MA056113A patent/MA56113A/fr unknown
- 2020-06-04 SG SG11202112461QA patent/SG11202112461QA/en unknown
-
2021
- 2021-02-26 US US17/187,504 patent/US11220501B2/en active Active
- 2021-11-29 US US17/537,113 patent/US20220298159A1/en active Pending
- 2021-12-01 IL IL288568A patent/IL288568A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2540017B2 (ja) | ５−ｈｔ１−様作用薬としてのインド―ル誘導体 | |
| HUT71593A (en) | Diketopiperazines, pharmaceutical compositions containing and process for producing the compounds | |
| US9469609B2 (en) | Synthesis of pyrrolidine compounds | |
| JP2004506638A (ja) | エポチロンアナログの多形 | |
| TW200526620A (en) | Pyrazine derivatives and pharmaceutical use thereof | |
| EP1296951B1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis | |
| JPH01311059A (ja) | １，３―二置換されたピロリジン | |
| JP2007521340A5 (ko) | ||
| JPH03176469A (ja) | イソインドロン誘導体 | |
| JPH07501337A (ja) | キノロン誘導体 | |
| CN1189832A (zh) | 用作磷酸二酯酶iv抑制剂的二氮杂䓬并吲哚 | |
| JP2020535168A5 (ko) | ||
| JPS63107972A (ja) | ２−フェニルベンズオキセピン誘導体及び該誘導体を含有する医薬 | |
| CN113683598A (zh) | 一种免疫调节剂 | |
| JPWO2020247643A5 (ko) | ||
| TWI772424B (zh) | 一種苯并呋喃類衍生物游離鹼的晶型及製備方法 | |
| TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
| US8138349B2 (en) | Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate | |
| KR20210134306A (ko) | 아크릴-함유 핵 수출 조절제들 및 이들의 용도들 | |
| JPWO2020210669A5 (ko) | ||
| KR20230088358A (ko) | 아미노 컴브리태스태틴(Amino combretastatin) 유도체 및 이의 응용 | |
| JP5856971B2 (ja) | 結晶性ｃｄｃ７阻害剤塩 | |
| CN110234631B (zh) | 用于治疗高血压和/或纤维化的组合物 | |
| KR20200142245A (ko) | 신규한 인다졸 유도체 화합물 및 이를 포함하는 암의 예방, 개선 또는 치료용 약학 조성물 | |
| JP3233276B2 (ja) | カッパアゴニストとしてのヒドラジド化合物 |